- Reaction score
- 347
Nope, Aderans failed to amplify mesenchymal stem cells (=dermal papillae) and that is why it ended.
On the other hand, Replicel achieved in amplifying another strand of cells, the sheath cup ones, and that is why Shiseido bought RCH-01 for the Asian market.
What's interesting is that Tsuji's trying to amplify those stem cells, Aderans failed to amplify, and, if he succeeds, those stem cells could be injected, as well.
I'm pretty confident that the injection of epithelial and mesenchymal stem cells will be proven to be a rather effective treatment for halting hair loss (presumably even restoration!).
I may not know the exact details about what strand of cells they multiplied or not but im 100% sure when i searched about the aderans trials they managed to halt all hairloss similar to Rch01 but they didnt manage regrowth, they had a viable hairloss treatment and they threw it away because it didnt produce any significant cosmetic result although itoffered sideless maintenance
Last edited: